Sunitinib MSN

GIF decision: Withdrawal from market, Marketing prohibition

What does this decision mean?

• Wycofanie z obrotu — Some of the products covered by the decision were withdrawn from the market — please return them to the pharmacy/distributor.
• Zakaz wprowadzania — Selected batches are subject to a marketing prohibition — the product cannot be distributed to pharmacies.

Leakage of capsules was found, with yellow powder present in intact blister pockets and a risk of environmental exposure to the cytotoxic substance spilling from the damaged capsule. Potential effects: poisoning, irritation and other toxic effects, lack of dose control of the medicine.

Download the app and stay informed

Get instant notifications about recalled products and protect your family.

App Store Google Play

Risk Level

High

Manufacturer

MSN Labs Europe Limited

Batch Number

CRE11018A

Notice Date

16.03.2026

What to do if you have this product?

A recall means the product may be unsafe. Here is what to do if you have it at home.

1

Do not eat or use the product

Stop using or consuming it immediately and keep it out of reach of children.
2

Check the batch number and expiry date

Compare the batch/lot number and the best-before or expiry date with the details in the alert — sometimes only specific batches are affected.
3

Return it to the shop

You can take the product back to the shop where you bought it. For a safety recall a refund is due even without a receipt.
4

Get help and report it

If you feel unwell after using the product, contact a doctor. You can also report the case to the relevant authority — GIS, GIF or UOKiK.

General guidance for recalled products in Poland. Always follow the specific instructions in the official alert and from the manufacturer or retailer.

Sunitinib MSN

What to do if you have this product?

Other Notices

Imuldosa

Loperamid APTEO MED

Tullex

Travoprost + Timolol Medical Valley

Kidofen